Henrik T Sorensen, MD, PhD
Adjunct Professor
Boston University School of Public Health
Epidemiology

MD, Aarhus University
PhD, Aalborg University
DMSc, Aarhus University



Henrik Toft Sørensen is professor of clinical epidemiology, and is founder and chair of Department of Clinical Epidemiology at Aarhus University Hospital, which was established in 2000. He is a physician and specialist in internal medicine and hepatology, has trained at several major Danish hospitals and acted as a clinician until 2005. He has been affiliated with Boston University since 2005.

Dr. Sørensen has more than 25 years of experience in clinical and epidemiological research. His research covers, among others, pharmacoepidemiology, epidemiological methods and determinants of the prognosis of several chronic diseases. Dr. Sørensen is author or co-author of more than 1,400 publications and has been supervisor for more than 60 doctoral students. He is Editor in Chief of Clinical Epidemiology.

Professor
Aarhus University Hospital
Epidemiology


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

Partial iCite Analysis       Copy PMIDs To Clipboard

  1. Skriver C, Maltesen T, Dehlendorff C, Skovlund CW, Schmidt M, Sørensen HT, Friis S. Long-term aspirin use and cancer risk: a 20-year cohort study. J Natl Cancer Inst. 2024 Apr 05; 116(4):530-538. PMID: 37966913
     
  2. Obel LM, Adelborg K, Pottegård A, Sørensen HT, Nybo M. Considerations for the Use of Biochemical Laboratory Registry Data in Clinical and Public Health Research. J Clin Epidemiol. 2024 Mar 29; 111337. PMID: 38556100
     
  3. Kristensen FPB, Horváth-Puhó E, Szépligeti SK, Troelsen FS, Sørensen HT. Risk of Bleeding and Venous Thromboembolism after Colorectal Cancer Surgery in Patients with and without Type 2 Diabetes: A Danish Cohort Study. TH Open. 2024 Jan; 8(1):e146-e154. PMID: 38532940; PMCID: PMC10965306; DOI: 10.1055/a-2275-9590;
     
  4. Bonnesen K, Poulsen CFB, Schmidt SAJ, Sørensen HT, Schmidt M. Autoimmune blistering disorders and cardiovascular risks: A population-based cohort study. J Am Acad Dermatol. 2024 Mar 15. PMID: 38492858
     
  5. Belza C, Szentkúti P, Horváth-Puhó E, Ray JG, Nelson KE, Grandi SM, Brown HK, Sørensen HT, Cohen E. Use of Latent Class Analysis to Predict Intensive Care Unit Admission and Mortality in Children with a Major Congenital Anomaly. J Pediatr. 2024 Mar 15; 114013. PMID: 38494089
     
  6. Boysen ML, Troelsen FS, Sørensen HT, Erichsen R. Type 2 diabetes mellitus and post-colonoscopy colorectal cancer: clinical and molecular characteristics and survival. Cancer Causes Control. 2024 Mar 14. PMID: 38483686
     
  7. Troelsen FS, Farkas DK, Erichsen R, Strate LL, Baron JA, Sørensen HT. Risk of Cancer in Patients with Diverticular Disease: A Population-based Cohort Study. Clin Gastroenterol Hepatol. 2024 Mar 13. PMID: 38490316
     
  8. Troelsen FS, Sørensen HT, Erichsen R. Risk of a post-colonoscopy colorectal cancer in patients with diverticular disease: a population-based cohort study. Endoscopy. 2024 Mar 13. PMID: 38331045
     
  9. Gribsholt SB, Schmidt M, Kristiansen EB, Richelsen B, Sørensen HT. Risk of cardiovascular disease after hospital-diagnosed overweight or obesity. Endocr Connect. 2024 Apr 01; 13(4). PMID: 38363150; PMCID: PMC10959045; DOI: 10.1530/EC-23-0452;
     
  10. Helmink MAG, Hageman SHJ, Eliasson B, Sattar N, Visseren FLJ, Dorresteijn JAN, Harris K, Peters SAE, Woodward M, Szentkúti P, Højlund K, Henriksen JE, Sørensen HT, Serné EH, van Sloten TT, Thomsen RW, Westerink J. Lifetime and 10-year cardiovascular risk prediction in individuals with type 1 diabetes: The LIFE-T1D model. Diabetes Obes Metab. 2024 Mar 08. PMID: 38456579
     
Showing 10 of 1551 results. Show More